Trajtimi i ri p\u00ebrfshin p\u00ebrdorimin e injeksioneve t\u00eb ocrelizumab, nj\u00eb terapi q\u00eb modifikon s\u00ebmundjen, e cila \u00ebsht\u00eb treguar e efektshme n\u00eb ndalimin e simptomave t\u00eb MS-s\u00eb. Pacient\u00ebt q\u00eb m\u00eb par\u00eb merrnin k\u00ebt\u00eb ila\u00e7 p\u00ebrmes infuzioneve q\u00eb zgjatnin deri n\u00eb kat\u00ebr or\u00eb, tani mund ta marrin at\u00eb p\u00ebrmes nj\u00eb injeksioni t\u00eb shpejt\u00eb, q\u00eb zgjat vet\u00ebm 10 minuta. Kjo metod\u00eb e re e administrimit zvog\u00eblon koh\u00ebn e kaluar n\u00eb spital me m\u00eb shum\u00eb se 90%, duke u dh\u00ebn\u00eb mund\u00ebsin\u00eb pacient\u00ebve t\u00eb kalojn\u00eb m\u00eb shum\u00eb koh\u00eb me familjet e tyre dhe t\u00eb p\u00ebrqendrohen n\u00eb jet\u00ebn e tyre t\u00eb p\u00ebrditshme.<\/p>\n\n\n\n
![\"\"](\"https:\/\/pemaejetes.org.al\/wp-content\/uploads\/2024\/07\/4928cac1-7c52-47f1-8323-e5d92a29dae4-1024x585.webp\")
<\/figure>\n\n\n\nP\u00ebrpar\u00ebsit\u00eb e injektimit t\u00eb ri
Ocrelizumab p\u00ebrfaq\u00ebson nj\u00eb p\u00ebrparim t\u00eb madh n\u00eb kujdesin e pacient\u00ebve me MS, ve\u00e7an\u00ebrisht p\u00ebr ata me form\u00ebn aktive relapsing ose primare progresive t\u00eb s\u00ebmundjes. Injeksioni n\u00ebnl\u00ebkuror, q\u00eb jepet dy her\u00eb n\u00eb vit, \u00ebsht\u00eb po aq efektiv sa infuzionet tradicionale, duke parandaluar rikthimin e simptomave dhe zhvillimin e lezioneve n\u00eb tru tek 97% e pacient\u00ebve p\u00ebr 48 jav\u00eb. Kjo metod\u00eb e re jo vet\u00ebm q\u00eb kursen koh\u00eb p\u00ebr pacient\u00ebt dhe stafin mjek\u00ebsor, por gjithashtu ofron nj\u00eb mund\u00ebsi p\u00ebr ata q\u00eb kan\u00eb v\u00ebshtir\u00ebsi me venat e v\u00ebshtira p\u00ebr t’u arritur.<\/p>\n\n\n\n
Nj\u00eb Ndikim pozitiv n\u00eb jet\u00ebn e pacient\u00ebve Llojet e Skleroz\u00ebs Multiple dhe Trajtimet e Disponueshme Fondacioni Pema e Jet\u00ebs angazhohet t\u00eb siguroj\u00eb mb\u00ebshtetje dhe informacion p\u00ebr t\u00eb gjith\u00eb ata q\u00eb vuajn\u00eb nga skleroza multiple n\u00eb Shqip\u00ebri, dhe ne shpresojm\u00eb se ky zhvillim i fundit do t\u00eb sjell\u00eb nj\u00eb ndryshim pozitiv n\u00eb jet\u00ebn e shum\u00eb njer\u00ebzve. P\u00ebr m\u00eb shum\u00eb informacion mbi trajtimin me ocrelizumab dhe mund\u00ebsit\u00eb e tjera t\u00eb trajtimit, ju lutemi kontaktoni Fondacionin ton\u00eb.<\/p>\n\n\n\n Fjal\u00eb ky\u00e7e SEO: Skleroz\u00eb multiple, trajtimi me ocrelizumab, injeksion n\u00ebnl\u00ebkuror, trajtime p\u00ebr MS, Fondacioni Pema e Jet\u00ebs, skleroza multiple n\u00eb Shqip\u00ebri, p\u00ebrmir\u00ebsimi i cil\u00ebsis\u00eb s\u00eb jet\u00ebs, MS relapsing remitting, MS primare progresive, MS sekondare progresive, simptomat e skleroz\u00ebs multiple, trajtimet modifikues t\u00eb s\u00ebmundjes.<\/p>\n\n\n\n Ky artikull \u00ebsht\u00eb publikuar nga Fondacioni Pema e Jet\u00ebs, nj\u00eb organizat\u00eb n\u00eb ndihm\u00eb t\u00eb personave q\u00eb vuajn\u00eb nga skleroza multiple n\u00eb Shqip\u00ebri.<\/p>\n","protected":false},"excerpt":{"rendered":" Fondacioni Pema e Jet\u00ebs ka k\u00ebnaq\u00ebsin\u00eb t\u00eb njoftoj\u00eb nj\u00eb lajm t\u00eb r\u00ebnd\u00ebsish\u00ebm p\u00ebr t\u00eb gjith\u00eb pacient\u00ebt q\u00eb vuajn\u00eb nga skleroza multiple (MS) n\u00eb Shqip\u00ebri. N\u00eb nj\u00eb p\u00ebrpjekje p\u00ebr t\u00eb p\u00ebrmir\u00ebsuar cil\u00ebsin\u00eb e jet\u00ebs s\u00eb k\u00ebtyre individ\u00ebve, NHS Anglia ka miratuar nj\u00eb trajtim t\u00eb ri inovativ, i cili premton t\u00eb zvog\u00ebloj\u00eb ndjesh\u00ebm koh\u00ebn e trajtimit spitalor […]<\/p>\n","protected":false},"author":2,"featured_media":1549,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[49,10],"tags":[],"class_list":["post-1548","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-semundjet-kronike","category-skleroza-multiple"],"acf":[],"yoast_head":"\n
Pacient\u00ebt si Nin Sambhi, nj\u00eb 39-vje\u00e7are nga Staffordshire, e diagnostikuar me MS relapsing n\u00eb vitin 2022, kan\u00eb p\u00ebrfituar ndjesh\u00ebm nga ky trajtim. Ajo thekson se trajtimi me injeksion do t\u00eb jet\u00eb m\u00eb i p\u00ebrshtatsh\u00ebm p\u00ebr t\u00eb dhe do t\u00eb leht\u00ebsoj\u00eb menaxhimin e jet\u00ebs s\u00eb saj familjare, duke i lejuar m\u00eb shum\u00eb koh\u00eb me f\u00ebmij\u00ebt e saj t\u00eb vegj\u00ebl.<\/p>\n\n\n\n![\"\"](\"https:\/\/pemaejetes.org.al\/wp-content\/uploads\/2024\/07\/b6f9a88a-cc2d-4435-bed0-9f3d1dbc864f-1024x585.webp\")
<\/figure>\n\n\n\n
Skleroza multiple \u00ebsht\u00eb nj\u00eb s\u00ebmundje q\u00eb prek trurin dhe palc\u00ebn kurrizore, duke shkaktuar nj\u00eb gam\u00eb t\u00eb gjer\u00eb simptomash, p\u00ebrfshir\u00eb problemet me shikimin, mobilitetin dhe ekuilibrin. Ekzistojn\u00eb tre lloje kryesore t\u00eb MS: MS relapsing remitting, MS primare progresive, dhe MS sekondare progresive. Trajtimet modifikues t\u00eb s\u00ebmundjes, si ocrelizumab, ndihmojn\u00eb n\u00eb reduktimin e rikthimeve dhe ngadal\u00ebsimin e p\u00ebrparimit t\u00eb s\u00ebmundjes.<\/p>\n\n\n\n